Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells

Thrombosis Research. Supplement
H FukaoO Matsuo

Abstract

The effect of fibrin stimulation on the fibrinolytic potential in cultured human umbilical vein endothelial cells (HUVEC) was investigated in the normal state and aged state. The amount of antigen of the two fibrinolytic factors, tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1), was determined using ELISA and the ABC method, respectively. When a fibrin clot was overlayered on the normal HUVEC, the secretion of t-PA or PAI-1 from the HUVEC was greatly changed. That is, PAI antigen was decreased 3-fold and t-PA antigen increased slightly in the conditioned medium. On the other hand, when the aged HUVEC were stimulated by a fibrin clot, PAI antigen was increased 3-fold and t-PA antigen did not change in the conditioned medium. When the level of fibrinolytic activity in the conditioned medium was expressed as the molar ratio of PAI and t-PA (PAI/t-PA), the value in the fibrin-stimulated normal HUVEC was markedly reduced (a 3.5-fold decrease) when compared with that of the non-stimulated normal HUVEC, reflecting a profibrinolytic state. On the other hand, the value in the fibrin-stimulated aged HUVEC was markedly increased (a 5-fold increase) when compared with that of the non-stimulated aged HU...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jan 1, 1986·The Journal of Clinical Investigation·T D Gelehrter, R Sznycer-Laszuk
Aug 1, 1986·The Journal of Clinical Investigation·M P BevilacquaD J Loskutoff
Jan 1, 1986·Haemostasis·O MatsuoS Izaki
Dec 1, 1984·The Journal of Clinical Investigation·E G LevinL A Harker
Sep 1, 1982·The Journal of Cell Biology·E G Levin, D J Loskutoff

❮ Previous
Next ❯

Citations

Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·A Hamsten
Jan 1, 1993·Baillière's Clinical Endocrinology and Metabolism·H H Newnham
Feb 9, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J P Bastard, L Piéroni
Mar 3, 1997·The Journal of Experimental Medicine·A R KitchingP G Tipping
Jul 19, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Laurent MesnardEric Rondeau
Aug 5, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Alexandre HertigEric Rondeau
May 18, 1999·The Journal of Biological Chemistry·A SahniC W Francis
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·A Sahni, C W Francis
Sep 16, 1992·Biochemical and Biophysical Research Communications·H FukaoO Matsuo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.